Abstract
BRK is a recently described non receptor protein tyrosine kinase whose mRNA was found to be expressed in human breast tumours and breast cancer cell lines. Expression of BRK in fibroblasts and mammary epithelial cells has been shown to enhance their ability to grow anchorage independently, and mammary epithelial cells expressing BRK acquire a potentiated mitogenic response to epidermal growth factor. In order to investigate further the expression of BRK in breast cancers, we have isolated monoclonal antibodies specifically recognising the protein. Whereas BRK expression was low or undetectable in normal mammary tissue and benign lesions, approximately two-thirds of breast tumours expressed appreciable levels, and 27% of tumours over expressed BRK by fivefold or more (up to 43×). This expression pattern was mirrored in a comparison of cell lines derived either from normal mammary epithelial cells or from carcinomas. BRK expression was found to be constant throughout the cell cycle, and did not vary with cell proliferation rate. A consideration of this expression data, in conjunction with BRK's demonstrated ability to deregulate the proliferation of mammary epithelial cells, supports the hypothesis that the over expression of BRK in a high proportion of breast carcinomas is a functionally important factor in their evolution.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barker, K., Jackson, L. & Crompton, M. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 15, 799–805 (1997). https://doi.org/10.1038/sj.onc.1201241
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201241
Keywords
This article is cited by
-
Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer
Journal of Experimental & Clinical Cancer Research (2021)
-
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
BMC Cancer (2019)
-
Multifaceted C-terminus of HSP70-interacting protein regulates tumorigenesis via protein quality control
Archives of Pharmacal Research (2019)
-
MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells
Scientific Reports (2017)
-
The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer
Chinese Journal of Cancer (2016)